All Stories

  1. Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum
  2. Update of variants identified in the pancreatic β‐cell K ATP channel genes KCNJ11 and ABCC8 in individuals with congenital hyperinsulinism and diabetes
  3. Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations
  4. 184-LB: Pancreatic Hypoplasia Patients Experience Poor Weight Gain and Labile Diabetes without Diabetic Ketoacidosis (DKA)
  5. 124-LB: Patients’ Experiences with a Do-It-Yourself Artificial Pancreas and Perspectives of the Endocrinologist’s Role in Supporting Their Use
  6. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison to GCK-MODY (MODY2)
  7. GCK-MODY in the US Monogenic Diabetes Registry: Description of 27 unpublished variants
  8. Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated
  9. Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals
  10. Correction: “Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals”
  11. Management and pregnancy outcomes of women with GCK-MODY enrolled in the US Monogenic Diabetes Registry
  12. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents
  13. Monogenic diabetes: the impact of making the right diagnosis
  14. Precision medicine in KCNJ11 permanent neonatal diabetes
  15. Clinical Utility of the T1D Genetic Risk Score—Examples from the U.S. Monogenic Diabetes Registry
  16. Identifying Patients with GDM at Risk for GCK-MODY
  17. Insulin Treatment and Clinical Outcomes in 67 Participants with Infancy-Onset Diabetes
  18. Management of GCK-MODY in Pregnancy—Does Clinical Practice Follow Current Recommendations?
  19. Reprogramming human T cell function and specificity with non-viral genome targeting
  20. White Matter Differences and Neurodevelopment Outcomes in Patients with KATP Channel-Related Diabetes
  21. Congenital Diabetes: Comprehensive Genetic Testing Allows for Improved Diagnosis and Treatment of Diabetes and Other Associated Features
  22. Congenital forms of diabetes: the beta-cell and beyond
  23. Neonatal Diabetes Mellitus
  24. Hypoglycemia in sulfonylurea-treated KCNJ11 -neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures
  25. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
  26. Early Intensive Insulin Use May Preserve Beta-Cell Function in Neonatal Diabetes Due to Mutations in the Proinsulin Gene
  27. Pancreatic Histopathology of Human Monogenic Diabetes Due to Causal Variants in KCNJ11, HNF1A, GATA6, and LMNA
  28. Diabetes Presentation in Infancy: High Risk of Diabetic Ketoacidosis
  29. Case Report: Preservation of Reduced Numbers of Insulin-Positive Cells in Sulfonylurea-Unresponsive KCNJ11-related Diabetes
  30. ADHD, learning difficulties and sleep disturbances associated with KCNJ11 -related neonatal diabetes
  31. Long Delay in Accurate Diagnosis of Hnf1A-Mody in the us Monogenic Diabetes Registry
  32. An online monogenic diabetes discussion group: supporting families and fueling new research
  33. Continued lessons from theINSgene: an intronic mutation causing diabetes through a novel mechanism
  34. Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes
  35. Response Letter to the Editor
  36. Sulfonylurea Treatment Before Genetic Testing in Neonatal Diabetes: Pros and Cons
  37. Hyperinsulinism in a Neonate
  38. Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
  39. Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 F333L Mutation
  40. Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations inIER3IP1: insights into the natural history of a rare disorder
  41. Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation inRFX6
  42. Gain-of-Function Mutations in the KATP Channel (KCNJ11) Impair Coordinated Hand-Eye Tracking
  43. Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype
  44. Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
  45. Genomic Sequencing in Newborn Screening Programs
  46. Genomic Sequencing in Newborn Screening Programs
  47. Neonatal Diabetes: An Expanding List of Genes Allows for Improved Diagnosis and Treatment
  48. Onset features and subsequent clinical evolution of childhood diabetes over several years
  49. HLA-DQ haplotypes differ by ethnicity in patients with childhood-onset diabetes
  50. Genetics and pathophysiology of neonatal diabetes mellitus
  51. The Cost-Effectiveness of Personalized Genetic Medicine
  52. Neonatal diabetes mellitus: A model for personalized medicine
  53. Update in neonatal diabetes
  54. Genetic Testing in Diabetes Mellitus
  55. Tooth Discoloration in Patients With Neonatal Diabetes After Transfer Onto Glibenclamide
  56. Diagnosis and treatment of neonatal diabetes: an United States experience†
  57. Insulin gene mutations as a cause of permanent neonatal diabetes
  58. Educating Future Leaders of Medical Research: Analysis of Student Opinions and Goals from the MD???PhD SAGE (Students??? Attitudes, Goals, and Education) Survey
  59. NOD B-cells Are Insufficient to Incite T-Cell-Mediated Anti-islet Autoimmunity
  60. Educational Views and Attitudes, and Career Goals of MD???PhD Students at the University of Pennsylvania School of Medicine
  61. MD-PhD Students in a Major Training Program Show Strong Interest in Becoming Surgeon-Scientists
  62. Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis
  63. The Role of T/B Lymphocyte Collaboration in the Regulation of Autoimmune and Alloimmune Responses
  64. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice
  65. B-Cell Deficiency and Type 1 Diabetes
  66. Impaired Activation of Islet-Reactive CD4 T Cells in Pancreatic Lymph Nodes of B Cell-Deficient Nonobese Diabetic Mice
  67. TRACKING ALLOREACTIVE CELL DIVISION IN VIVO1
  68. A DIRECT METHOD FOR THE CALCULATION OF ALLOREACTIVE CD4+ T CELL PRECURSOR FREQUENCY1
  69. CD28 COSTIMULATION IN ALLOIMMUNE RESPONSES AGAINST MAJOR AND MINOR HISTOCOMPATIBILITY ANTIGENS
  70. B lymphocytes influence the shape of the mature preimmune CD4+ TCR repertoire
  71. Characterization of the alloimmune response to minor histocompatibility antigens by in vivo MLR
  72. In vivo MLR: a novel method for the study of alloimmune responses